Dora Ferrari
Corporate Officer/Principal bij CURIS, INC.
Profiel
Dora Ferrari is currently the Vice President-Clinical Operations at Curis, Inc. Prior to this, she worked as the Director-Clinical Development & Program Management at ArQule, Inc., a Clinical Research Associate at EPIX Pharmaceuticals, Inc., and the VP-Clinical Development & Program Management at Aileron Therapeutics, Inc. She completed her undergraduate degree at the University of Massachusetts.
Actieve functies van Dora Ferrari
| Bedrijven | Functie | Begin |
|---|---|---|
| CURIS, INC. | Corporate Officer/Principal | 03-01-2021 |
Eerdere bekende functies van Dora Ferrari
| Bedrijven | Functie | Einde |
|---|---|---|
| ARQULE, INC. | Corporate Officer/Principal | - |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Corporate Officer/Principal | - |
| AILERON THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Dora Ferrari
| University of Massachusetts | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| CURIS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
